A detailed history of Coastal Bridge Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 17,398 shares of JNJ stock, worth $2.89 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
17,398
Previous 17,315 0.48%
Holding current value
$2.89 Million
Previous $2.74 Million 7.19%
% of portfolio
0.72%
Previous 0.7%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$144.38 - $157.78 $11,983 - $13,095
83 Added 0.48%
17,398 $2.54 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $6,053 - $6,346
39 Added 0.23%
17,315 $2.74 Million
Q4 2023

Feb 15, 2024

BUY
$145.6 - $158.88 $5,824 - $6,355
40 Added 0.23%
17,276 $2.71 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $62,767 - $70,315
-403 Reduced 2.28%
17,236 $2.68 Million
Q2 2023

Aug 16, 2023

SELL
$154.35 - $166.11 $172,872 - $186,043
-1,120 Reduced 5.97%
17,639 $2.92 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $87,155 - $104,010
577 Added 3.17%
18,759 $2.91 Million
Q4 2022

Feb 08, 2023

BUY
$160.2 - $179.79 $38,448 - $43,149
240 Added 1.34%
18,182 $3.21 Million
Q3 2022

Nov 15, 2022

SELL
$161.33 - $179.52 $9,034 - $10,053
-56 Reduced 0.31%
17,942 $2.93 Million
Q2 2022

Nov 15, 2022

SELL
$168.19 - $186.01 $87,963 - $97,283
-523 Reduced 2.82%
17,998 $3.2 Million
Q2 2022

Aug 05, 2022

BUY
$168.19 - $186.01 $111,341 - $123,138
662 Added 3.71%
18,521 $3.29 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $4,586 - $5,208
29 Added 0.16%
17,859 $3.17 Million
Q4 2021

May 20, 2022

SELL
$155.93 - $173.01 $411,655 - $456,746
-2,640 Reduced 12.9%
17,830 $3.05 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $418,048 - $463,839
2,681 Added 15.07%
20,470 $3.5 Million
Q3 2021

May 20, 2022

SELL
$161.5 - $179.47 $418,285 - $464,827
-2,590 Reduced 12.71%
17,789 $2.87 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $294,899 - $327,712
1,826 Added 9.84%
20,379 $3.29 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $380,997 - $408,686
2,389 Added 14.78%
18,553 $3.06 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $276,444 - $307,886
1,806 Added 12.58%
16,164 $2.66 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $197,986 - $227,256
-1,444 Reduced 9.14%
14,358 $2.26 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $56,152 - $61,532
-400 Reduced 2.47%
15,802 $2.35 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $35,036 - $42,298
272 Added 1.71%
16,202 $2.28 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $104,582 - $144,904
941 Added 6.28%
15,930 $2.09 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $36,210 - $41,588
-284 Reduced 1.86%
14,989 $2.19 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $88,611 - $99,213
698 Added 4.79%
15,273 $1.98 Million
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $1.48 Million - $1.62 Million
11,257 Added 339.27%
14,575 $2.03 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $1.49 Million - $1.63 Million
-11,330 Reduced 77.35%
3,318 $2.1 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $199,391 - $221,706
-1,586 Reduced 9.77%
14,648 $2.05 Million
Q4 2018

Feb 08, 2019

BUY
$122.84 - $147.84 $71,861 - $86,486
585 Added 3.74%
16,234 $2.1 Million
Q3 2018

Nov 08, 2018

BUY
$121.58 - $142.88 $145,896 - $171,456
1,200 Added 8.31%
15,649 $2.16 Million
Q2 2018

Aug 03, 2018

BUY
$119.4 - $131.76 $23,521 - $25,956
197 Added 1.38%
14,449 $1.75 Million
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $223,178 - $264,281
-1,784 Reduced 11.12%
14,252 $1.83 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $206,277 - $225,770
-1,572 Reduced 8.93%
16,036 $2.23 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $14,759 - $15,433
114 Added 0.65%
17,608 $2.29 Million
Q1 2017

Aug 14, 2017

BUY
N/A
17,494
17,494 $2.18 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.